These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8088396)

  • 21. Postprocedure administration of insulin in canine autologous vein grafting: a potential strategy to attenuate intimal hyperplasia.
    Zhou N; Yu QJ; Si R; Gao HK; Wang T; Gao F; Wang HC; Bian JF
    J Cardiovasc Pharmacol; 2010 Oct; 56(4):402-12. PubMed ID: 20625311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of low molecular weight heparin on intimal hyperplasia in vein grafts.
    Wilson NV; Salisbury JR; Kakkar VV
    Eur J Vasc Surg; 1994 Jan; 8(1):60-4. PubMed ID: 8307218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. c-Jun regulates shear- and injury-inducible Egr-1 expression, vein graft stenosis after autologous end-to-side transplantation in rabbits, and intimal hyperplasia in human saphenous veins.
    Ni J; Waldman A; Khachigian LM
    J Biol Chem; 2010 Feb; 285(6):4038-4048. PubMed ID: 19940138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. L-arginine inhibits smooth muscle cell proliferation of vein graft intimal thickness in hypercholesterolemic rabbits.
    Okazaki J; Komori K; Kawasaki K; Eguchi D; Ishida M; Sugimachi K
    Cardiovasc Res; 1997 Dec; 36(3):429-36. PubMed ID: 9534863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adventitial delivery of platelet-derived endothelial cell growth factor gene prevented intimal hyperplasia of vein graft.
    Handa M; Li W; Morioka K; Takamori A; Yamada N; Ihaya A
    J Vasc Surg; 2008 Dec; 48(6):1566-74. PubMed ID: 18848756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of vein graft intimal and medial thickening by periadventitial application of a sulfated carbohydrate polymer.
    Toes GJ; Barnathan ES; Liu H; Raghunath PN; Tomaszewski JE; Caron RJ; Weisz PB; van Oeveren W; Golden MA
    J Vasc Surg; 1996 Apr; 23(4):650-6. PubMed ID: 8627902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Celiprolol reduces the intimal thickening of autogenous vein grafts via an enhancement of nitric oxide function through an inhibition of superoxide production.
    Hattori K; Yamanouchi D; Banno H; Kobayashi M; Yamamoto K; Kajikuri J; Itoh T; Komori K
    J Vasc Surg; 2007 Jul; 46(1):116-23. PubMed ID: 17606127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Local shRNA modulation of phosphatidylinositol 3-kinase signaling pathway reduces intimal hyperplasia in vein grafts: experiment with rats].
    Deng YZ; Liu SJ; Ma L; Sun ZQ; Chen JJ; Su G; Liu C; Wang GH; Ke J
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(24):1713-6. PubMed ID: 17825157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination therapy of cholesterol reduction and L-arginine supplementation controls accelerated vein graft atheroma.
    Davies MG; Fulton GJ; Huynh TT; Barber L; Svendsen E; Hagen PO
    Ann Vasc Surg; 1999 Sep; 13(5):484-93. PubMed ID: 10466992
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Local inhibition of tyrosine kinase activity markedly attenuates the development of intimal hyperplasia in experimental vein grafts.
    Huynh TT; Davies MG; Barber L; Svendsen E; Hagen PO
    J Surg Res; 1998 Jul; 77(2):104-11. PubMed ID: 9733595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of cell surface expression of endothelial adhesion molecules by ursolic acid prevents intimal hyperplasia of venous bypass grafts in rats.
    Zeller I; Wiedemann D; Schwaiger S; Stelzmüller M; Kreutmayer S; Leberfing O; Stuppner H; Bernhard D
    Eur J Cardiothorac Surg; 2012 Nov; 42(5):878-84. PubMed ID: 22551965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Local delivery of a tissue factor antibody reduces early leukocyte infiltration but fails to limit intimal hyperplasia in experimental vein grafts.
    Annex BH; Davies MG; Fulton GJ; Huynh TT; Channon KM; Ezekowitz MD; Hagen PO
    J Surg Res; 1998 Dec; 80(2):164-70. PubMed ID: 9878308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Local treatment with recombinant tissue factor pathway inhibitor reduces the development of intimal hyperplasia in experimental vein grafts.
    Huynh TT; Davies MG; Thompson MA; Ezekowitz MD; Hagen P; Annex BH
    J Vasc Surg; 2001 Feb; 33(2):400-7. PubMed ID: 11174796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Topical mitogen-activated protein kinases inhibition reduces intimal hyperplasia in arterialized vein grafts.
    Gulkarov I; Bohmann K; Cinnante KM; Pirelli L; Yu PJ; Grau JB; Pintucci G; Galloway AC; Mignatti P
    J Surg Res; 2009 Jun; 154(1):150-6. PubMed ID: 18805551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of dopamine-mediated relaxation in experimental vein bypass grafts.
    Davies MG; Huynh TT; Hagen PO
    J Surg Res; 2000 Jul; 92(1):103-7. PubMed ID: 10864489
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of smooth muscle cell migration and neointima formation in vein grafts by overexpression of matrix metalloproteinase-3.
    Kallenbach K; Salcher R; Heim A; Karck M; Mignatti P; Haverich A
    J Vasc Surg; 2009 Mar; 49(3):750-8. PubMed ID: 19268777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suppressors of oxygen metabolites fail to reduce vein graft intimal hyperplasia.
    Gates JD; Hirsch GM; Karnovsky MJ
    Arch Surg; 1995 Sep; 130(9):976-80. PubMed ID: 7661683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduction of experimental vein graft intimal hyperplasia by ketanserin.
    Massey MF; Davies MG; Svendsen E; Klyachkin ML; Schwartz LB; Barber L; McCann RL; Hagen PO
    J Surg Res; 1993 Jun; 54(6):530-8. PubMed ID: 8412062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. All-trans-retinoic acid decreases vein graft intimal hyperplasia and matrix metalloproteinase activity in vivo.
    Leville CD; Dassow MS; Seabrook GR; Jean-Claude JM; Towne JB; Cambria RA
    J Surg Res; 2000 May; 90(2):183-90. PubMed ID: 10792961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of microRNA-145 to prevent vein graft disease in rabbits by regulation of smooth muscle cell phenotype.
    Ohnaka M; Marui A; Yamahara K; Minakata K; Yamazaki K; Kumagai M; Masumoto H; Tanaka S; Ikeda T; Sakata R
    J Thorac Cardiovasc Surg; 2014 Aug; 148(2):676-82.e2. PubMed ID: 24507892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.